Moderna will replace Warner Bros. Discovery in the Nasdaq-100 Index effective October 9, 2026.
Quiver AI Summary
Nasdaq announced that Moderna, Inc. will be added to the Nasdaq-100 Index, replacing Warner Bros. Discovery, Inc., effective before the market opens on October 9, 2026. The Nasdaq-100 Index tracks the performance of 100 of the largest non-financial companies listed on Nasdaq and is a key benchmark followed by numerous investment products globally. Nasdaq Global Indexes, which maintains over 10,000 indexes, supports economic opportunity through advanced technology and data solutions. For more information, Nasdaq encourages visiting their website or social media channels.
Potential Positives
- Moderna, Inc. being added to the Nasdaq-100 Index® signifies a recognition of its market value and importance, potentially increasing investor interest and stock performance.
- This change reflects positively on Nasdaq’s role as a leading index provider, enhancing its reputation and attracting more funds that track the Nasdaq-100 Index®.
- The transition from Warner Bros. Discovery, Inc. to Moderna, Inc. indicates a shift in market dynamics, showcasing a focus on biotech and innovation-driven companies within the index.
- The Nasdaq-100 Index® being tracked by over $800 billion in assets highlights the significance of the index and its components, which may lead to increased trading volume and liquidity for Moderna's shares.
Potential Negatives
- Moderna is replacing Warner Bros. Discovery in the Nasdaq-100 Index, which may highlight a decrease in Warner Bros.' performance or relevance, creating a perception that the index is removing underperforming companies.
- The press release states that Nasdaq's proprietary indexes are not guarantees of future performance, which could raise concerns among investors about the stability or reliability of the indexes.
- The explicit warning that advice from a securities professional is strongly advised may indicate potential risks or uncertainties surrounding investments tied to Nasdaq indexes, potentially decreasing investor confidence.
FAQ
What significant change is happening to the Nasdaq-100 Index?
Moderna, Inc. will replace Warner Bros. Discovery in the Nasdaq-100 Index on October 9, 2026.
When will the change to the Nasdaq-100 Index take place?
The change will occur before market open on Friday, October 9, 2026.
Who provides the Nasdaq Global Indexes?
Nasdaq Global Indexes is one of the world's leading index providers offering various benchmarks and indexes.
What does the Nasdaq-100 Index measure?
It measures the performance of 100 of the largest non-financial companies listed on Nasdaq.
How can I get notified about changes to Nasdaq Indexes?
For notifications on changes, visit https://indexes.nasdaq.com/ for more information.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NDAQ Insider Trading Activity
$NDAQ insiders have traded $NDAQ stock on the open market 17 times in the past 6 months. Of those trades, 1 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:
- AB INVESTOR purchased 56,782 shares for an estimated $4,882,116
- PC NELSON GRIGGS (Pres. Capital Access Platforms) has made 0 purchases and 5 sales selling 37,116 shares for an estimated $3,504,314.
- BRADLEY J PETERSON (EVP, CIO) has made 0 purchases and 3 sales selling 26,710 shares for an estimated $2,477,452.
- COHEN TAL (Pres. Market Platforms) sold 15,518 shares for an estimated $1,408,258
- JEREMY SKULE (EVP, CSO) has made 0 purchases and 3 sales selling 4,500 shares for an estimated $426,060.
- BRYAN EVERARD SMITH (EVP, CPO) has made 0 purchases and 2 sales selling 4,556 shares for an estimated $408,658.
- MICHELLE LYNN DALY (SVP, Controller & PAO) has made 0 purchases and 2 sales selling 1,323 shares for an estimated $117,512.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NDAQ Revenue
$NDAQ had revenues of $2.5B in Q2 2026. This is an increase of 21.15% from the same period in the prior year.
You can track NDAQ financials on Quiver Quantitative's NDAQ stock page.
You can access data on NDAQ stock through the Quiver Quantitative API.
$NDAQ Congressional Stock Trading
Members of Congress have traded $NDAQ stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/24 and 1 sale worth up to $250,000 on 08/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$NDAQ Hedge Fund Activity
We have seen 504 institutional investors add shares of $NDAQ stock to their portfolio, and 504 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 5,946,692 shares (-16.4%) from their portfolio in Q2 2026, for an estimated $468,718,263
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 5,800,900 shares (-20.0%) from their portfolio in Q2 2026, for an estimated $457,226,937
- JPMORGAN CHASE & CO added 3,655,221 shares (+inf%) to their portfolio in Q2 2026, for an estimated $288,104,519
- JANE STREET GROUP, LLC added 2,863,049 shares (+2779.3%) to their portfolio in Q2 2026, for an estimated $225,665,522
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,828,483 shares (+inf%) to their portfolio in Q2 2026, for an estimated $222,941,030
- BARCLAYS PLC added 1,844,889 shares (+140.5%) to their portfolio in Q2 2026, for an estimated $145,414,150
- D. E. SHAW & CO., INC. added 1,669,406 shares (+168.2%) to their portfolio in Q2 2026, for an estimated $131,582,580
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NDAQ Price Targets
Multiple analysts have issued price targets for $NDAQ recently. We have seen 4 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $103.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $108.0 on 07/09/2026
- Patrick O'Shaughnessy from Raymond James set a target price of $113.0 on 07/09/2026
- Bill Katz from TD Cowen set a target price of $98.0 on 06/22/2026
- Chris Allen from Keefe, Bruyette & Woods set a target price of $97.0 on 04/24/2026
Full Release
NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index ® (NDX ® ) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD) prior to market open on Friday, October 9, 2026.
For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/
About Nasdaq Global Indexes
Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index ® — which measures the performance of 100 of the largest Nasdaq-listed non-financial companies — is tracked by more than 200 investment products with over $800 billion in assets under management globally. Nasdaq Global Indexes publishes and maintains more than 10,000 indexes across asset classes and geographies.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the infrastructure of the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying advanced technology, data, and intelligence solutions that enable our clients to capture opportunities, navigate risk, and strengthen resilience. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.
Nasdaq ® , Nasdaq -100 Index ® and NDX ® a re registered trademark s of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq , Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Media Contact
Maximilian Leitenberger
[email protected]
Issuer & Investor Contact
Index Client Services
[email protected]
-NDAQF-
